Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

Abstract:

:Advanced Bladder Cancer (BLCA) remains a clinical challenge that lacks effective therapeutic measures. Here, we show that distinct, stage-wise metabolic alterations in BLCA are associated with the loss of function of aldehyde oxidase (AOX1). AOX1 associated metabolites have a high predictive value for advanced BLCA and our findings demonstrate that AOX1 is epigenetically silenced during BLCA progression by the methyltransferase activity of EZH2. Knockdown (KD) of AOX1 in normal bladder epithelial cells re-wires the tryptophan-kynurenine pathway resulting in elevated NADP levels which may increase metabolic flux through the pentose phosphate (PPP) pathway, enabling increased nucleotide synthesis, and promoting cell invasion. Inhibition of NADP synthesis rescues the metabolic effects of AOX1 KD. Ectopic AOX1 expression decreases NADP production, PPP flux and nucleotide synthesis, while decreasing invasion in cell line models and suppressing growth in tumor xenografts. Further gain and loss of AOX1 confirm the EZH2-dependent activation, metabolic deregulation, and tumor growth in BLCA. Our findings highlight the therapeutic potential of AOX1 and provide a basis for the development of prognostic markers for advanced BLCA.

journal_name

Oncogene

journal_title

Oncogene

authors

Vantaku V,Putluri V,Bader DA,Maity S,Ma J,Arnold JM,Rajapakshe K,Donepudi SR,von Rundstedt FC,Devarakonda V,Dubrulle J,Karanam B,McGuire SE,Stossi F,Jain AK,Coarfa C,Cao Q,Sikora AG,Villanueva H,Kavuri SM,Lotan Y

doi

10.1038/s41388-019-0902-7

subject

Has Abstract

pub_date

2020-10-01 00:00:00

pages

6265-6285

issue

40

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-019-0902-7

journal_volume

39

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The v-rel and c-rel proteins exist in high molecular weight complexes in avian and murine cells.

    abstract::We reported previously that the v-rel protein (p59v-rel) exists in a high molecular weight complex with at least four other proteins in the cytoplasm of v-rel-transformed chicken pre-B lymphoid cells (Simek, S. & Rice, N.R., J. Virol., 62, 4730-4736, 1989). One of these proteins is the chicken c-rel protein, but the i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kochel T,Mushinski JF,Rice NR

    更新日期:1991-04-01 00:00:00

  • Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways.

    abstract::Overexpression of hepatocyte growth factor (HGF), also called scatter factor (SF), and its receptor c-Met are associated with poor prognosis for cancer patients. In particular, breast cancer cells can produce HGF that acts in a paracrine as well as in an autocrine manner. Therefore, HGF and c-Met are putative targets ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207063

    authors: Gallego MI,Bierie B,Hennighausen L

    更新日期:2003-11-20 00:00:00

  • Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.

    abstract::tal-1 deletions are caused by a site specific recombination, which exclusively occurs in 12-26% of T-cell acute lymphoblastic leukemias (T-ALL). In a previous study on a large series of T-ALL we demonstrated an apparent preferential occurrence of tal-1 deletions in CD3- and CD3+ alpha beta lineage T-ALL with TcR-delta...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Breit TM,Wolvers-Tettero IL,van Dongen JJ

    更新日期:1994-07-01 00:00:00

  • High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF.

    abstract::We recently reported the cloning and overexpression of full-length forms of human fibroblast growth factor (FGF) receptors, bek and flg. These receptors contain three immunoglobulin (Ig)-like domains and an unusual acidic motif in the extracellular region, a single transmembrane segment and a protein tyrosine kinase c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crumley G,Bellot F,Kaplow JM,Schlessinger J,Jaye M,Dionne CA

    更新日期:1991-12-01 00:00:00

  • A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.

    abstract::To gain better understanding of the molecular alterations responsible for the aggressive growth potential of epidermal growth factor receptor (EGFR)-positive breast cancers, we utilized an expression cloning strategy to seek gene products that mediate the EGF-independent growth of human breast cancer cells. A retrovir...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204537

    authors: Berquin IM,Dziubinski ML,Nolan GP,Ethier SP

    更新日期:2001-07-05 00:00:00

  • ZNF185, an actin-cytoskeleton-associated growth inhibitory LIM protein in prostate cancer.

    abstract::We have recently identified ZNF185 as a gene that is downregulated in prostate cancer (PCa), in part via epigenetic alteration, and maybe associated with disease progression. In this study, we cloned the ZNF185 cDNA from normal human prostate tissues and investigated its biological function. We show that ZNF185 is a n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209769

    authors: Zhang JS,Gong A,Young CY

    更新日期:2007-01-04 00:00:00

  • Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding.

    abstract::Endothelial cells expressing fibroblast growth factor receptor-1 (FGFR-1) migrate and proliferate in response to treatment with FGF. We analysed ligand-induced migration and proliferation of porcine aortic endothelial cells expressing wild-type FGFR-1, point-mutated Y766F FGFR-1, unable to activate phospholipase C-gam...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201936

    authors: Landgren E,Klint P,Yokote K,Claesson-Welsh L

    更新日期:1998-07-23 00:00:00

  • HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.

    abstract::Transcription factor PAX8 expression is upregulated in several types of cancers. However, little is known about the function of PAX8 in the progression of hepatoma and its regulatory mechanisms. Here, we show that PAX8 silencing inhibits the proliferation and clonogenicity of hepatoma cells and its growth in vivo. The...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0907-2

    authors: Wang J,Li N,Huang ZB,Fu S,Yu SM,Fu YM,Zhou PC,Chen RC,Zhou RR,Huang Y,Hu XW,Fan XG

    更新日期:2019-10-01 00:00:00

  • Murine WNT11 is a secreted glycoprotein that morphologically transforms mammary epithelial cells.

    abstract::Wnt genes encode a set of structurally related cell surface glycoproteins that appear to have roles in cell-cell signalling. The ectopic expression of several murine Wnt genes has been implicated in the transformation of mammary epithelial and the onset of mammary tumours. Wnt11 is expressed in the developing embryo i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Christiansen JH,Monkley SJ,Wainwright BJ

    更新日期:1996-06-20 00:00:00

  • Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

    abstract::Imatinib-acquired resistance related to the presence of secondary point mutations has become a frequent event in gastrointestinal stromal tumors. Here, transient transfection experiments with plasmids carrying two different KIT-acquired point mutations were performed along with immunoprecipitation of total protein ext...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209639

    authors: Tamborini E,Pricl S,Negri T,Lagonigro MS,Miselli F,Greco A,Gronchi A,Casali PG,Ferrone M,Fermeglia M,Carbone A,Pierotti MA,Pilotti S

    更新日期:2006-10-05 00:00:00

  • Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression.

    abstract::The W locus of mice encodes the c-kit receptor tyrosine kinase. Recently, we characterized a novel mutant allele, Wn, and demonstrated that the c-kit protein synthesized in Wn/Wn cultured mast cells (CMC) was reduced in size and not expressed on their surface (Tsujimura et al., 1993). In this study, we further examine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Koshimizu U,Tsujimura T,Isozaki K,Nomura S,Furitsu T,Kanakura Y,Kitamura Y,Nishimune Y

    更新日期:1994-01-01 00:00:00

  • Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic mice.

    abstract::To investigate the tumorigenic potential of mutant p53 when selectively expressed in lung tissue, a transgenic mouse model was developed in which a mutant form of p53 (p53-273H) was placed under the transcriptional control of the lung-specific human surfactant protein C (SP-C) promoter. Two founder mice were identifie...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205909

    authors: Duan W,Ding H,Subler MA,Zhu WG,Zhang H,Stoner GD,Windle JJ,Otterson GA,Villalona-Calero MA

    更新日期:2002-11-07 00:00:00

  • Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.

    abstract::Activating mutations of K-ras are frequent in colon tumors and aberrant crypt foci, and may play important roles in colon carcinogenesis. Here, we investigated the effects of a K-ras codon 12 mutation on inducible nitric oxide synthase (iNOS) expression. When rat intestinal epithelial cells (IEC-6) were transfected wi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207051

    authors: Takahashi M,Mutoh M,Shoji Y,Kamanaka Y,Naka M,Maruyama T,Sugimura T,Wakabayashi K

    更新日期:2003-10-23 00:00:00

  • Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.

    abstract::The oncoprotein c-Myc contains two dimerization motifs- the helix-loop-helix (HLH) and the leucine zipper (LZ) - through which c-Myc specifically dimerizes with Max. We substituted regions of the c-Myc HLH and LZ motifs with the corresponding regions of structurally related proteins that do not interact with Max. Spec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Davis LJ,Halazonetis TD

    更新日期:1993-01-01 00:00:00

  • Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.

    abstract::A candidate gene (WT1) has recently been described for the 11p13 tumour-suppressor gene involved in the development of Wilms' tumour. This gene encodes a zinc finger protein which can bind to a specific DNA sequence. We have found a 226 base deletion in the mRNA from a unilateral Wilms' tumour, which would cause a fra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Brown KW,Watson JE,Poirier V,Mott MG,Berry PJ,Maitland NJ

    更新日期:1992-04-01 00:00:00

  • Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks.

    abstract::The diverse checkpoint responses to DNA damage may reflect differential sensitivities by molecular components of the damage-signalling network to the type and amount of lesions. Here, we determined the kinetics of activation of the checkpoint kinases ATM and Chk2 (the latter substrate of ATM) in relation to the initia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207986

    authors: Buscemi G,Perego P,Carenini N,Nakanishi M,Chessa L,Chen J,Khanna K,Delia D

    更新日期:2004-10-07 00:00:00

  • Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.

    abstract::Although cyclin D1 is overexpressed in a significant number of human cancers, overexpression alone is insufficient to promote tumorigenesis. In vitro studies have revealed that inhibition of cyclin D1 nuclear export unmasks its neoplastic potential. Cyclin D1 nuclear export depends upon phosphorylation of a C-terminal...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209644

    authors: Benzeno S,Lu F,Guo M,Barbash O,Zhang F,Herman JG,Klein PS,Rustgi A,Diehl JA

    更新日期:2006-10-12 00:00:00

  • P63 regulates tubular formation via epithelial-to-mesenchymal transition.

    abstract::P63, a p53 family member, is expressed as TA and ΔN isoforms. Interestingly, both TAp63 and ΔNp63 are transcription factors, and regulate both common and distinct sets of target genes. p63 is required for survival of some epithelial cell lineages, and lack of p63 leads to loss of epidermis and other epithelia in human...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.101

    authors: Zhang Y,Yan W,Chen X

    更新日期:2014-03-20 00:00:00

  • Identification of novel VHL targets that are associated with the development of renal cell carcinoma.

    abstract::von Hippel-Lindau (VHL) disease is a dominantly inherited family cancer syndrome characterized by the development of retinal and central nervous system haemangioblastomas, renal cell carcinoma (RCC) and phaeochromocytoma. Specific germline VHL mutations may predispose to haemangioblastomas, RCC and phaeochromocytoma t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209932

    authors: Abdulrahman M,Maina EN,Morris MR,Zatyka M,Raval RR,Banks RE,Wiesener MS,Richards FM,Johnson CM,Latif F,Maher ER

    更新日期:2007-03-08 00:00:00

  • Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.

    abstract::Glioblastoma (GBM) is a highly malignant glioma, which has the propensity to infiltrate throughout the brain in contrast to pilocytic astrocytoma (PA) of the posterior fossa, which does not spread and can be cured by surgery. We have used Suppression Subtractive Hybridization to define markers that better delineate th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209305

    authors: Colin C,Baeza N,Bartoli C,Fina F,Eudes N,Nanni I,Martin PM,Ouafik L,Figarella-Branger D

    更新日期:2006-05-04 00:00:00

  • Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis.

    abstract::Protein phosphatase inhibitors are often considered as tumor promoters. Protein phosphatase 1 regulatory subunit 1A (PPP1R1A) is a potent protein phosphatase 1 (PP1) inhibitor; however, its role in tumor development is largely undefined. Here we characterize, for the first time, the functions of PPP1R1A in Ewing sarco...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.378

    authors: Luo W,Xu C,Ayello J,Dela Cruz F,Rosenblum JM,Lessnick SL,Cairo MS

    更新日期:2018-02-08 00:00:00

  • Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5'UTR.

    abstract::eIF4E is essential for translation initiation, but its overexpression causes malignant transformation. Recent work demonstrated that eIF4E/F participates in exposing and locating alternate translation start codons during scanning. Translation initiation of several important protooncogenes and growth-regulators, such a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202890

    authors: Carter PS,Jarquin-Pardo M,De Benedetti A

    更新日期:1999-07-29 00:00:00

  • Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.

    abstract::Constitutive activation of the phosphoinositide 3-kinase (PI3K)-AKT pathway is observed in up to 70% of acute myelogenous leukemia. To investigate the relevance of an intrinsic PI3K-AKT pathway activation in hematopoietic malignancies, we analysed the effect of point mutations in the catalytic (p110alpha) and regulato...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.40

    authors: Horn S,Bergholz U,Jücker M,McCubrey JA,Trümper L,Stocking C,Bäsecke J

    更新日期:2008-07-03 00:00:00

  • Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts.

    abstract::The MAP kinase pathway impinging on ERK2 has been shown to be integrally associated with mitogenic signalling in many cell types. Previously, we and others have demonstrated that oncogenic forms of Raf-1 kinase, when expressed in fibroblasts, lead to the constitutive activation of ERK2, the de-regulation of c-fos expr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kortenjann M,Shaw PE

    更新日期:1995-11-16 00:00:00

  • The PGC-1/ERR signaling axis in cancer.

    abstract::Proliferating cells need to produce a large amount of energy and, at the same time, need to maintain a constant supply of biosynthetic precursors of macromolecules that are used as building blocks for generating new cells. Indeed, many cancer cells undergo a switch from mitochondrial to glycolytic metabolism and displ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.529

    authors: Deblois G,St-Pierre J,Giguère V

    更新日期:2013-07-25 00:00:00

  • Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.

    abstract::Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular endothelial cell growth factor (VEGF) is known to be one of the most important inducers of angiogenesis and is upregulated in carcinoma of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203817

    authors: López-Ocejo O,Viloria-Petit A,Bequet-Romero M,Mukhopadhyay D,Rak J,Kerbel RS

    更新日期:2000-09-21 00:00:00

  • RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells.

    abstract::The S-phase kinase-associated protein-2 (SKP2) plays a key role in ubiquitin-mediated proteolysis, which results in the progression of cells from a quiescence to proliferative state. SKP2 is overexpressed in a variety of tumors. In this study, we used small interfering RNAs (siRNAs) to inhibit the SKP2 expression in l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208459

    authors: Jiang F,Caraway NP,Li R,Katz RL

    更新日期:2005-05-12 00:00:00

  • Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.

    abstract::We have evaluated the transcriptional activation of a human p21 promoter reporter construct by transfection of BRCA1 expression constructs into tumorigenic and nontumorigenic human breast cell lines. Two cell lines with wildtype p53 (MCF-7 and MCF10A) demonstrated transcriptional activation of the p21 promoter by full...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204025

    authors: Lu M,Arrick BA

    更新日期:2000-12-14 00:00:00

  • Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

    abstract::Sp1 is important for the transcription of many genes. Our previous studies have shown that Sp1 is degraded in normal cell, but it is preserved in cancer cells during mitosis and exists a priori in the daughter cells, ready to engage in gene transcription and thereby contributes to the proliferation and survival of can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.649

    authors: Chuang JY,Wang SA,Yang WB,Yang HC,Hung CY,Su TP,Chang WC,Hung JJ

    更新日期:2012-11-22 00:00:00

  • Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific protease.

    abstract::Degradation of cellular proteins through ubiquitination is a fundamental strategy for regulating biological pathways. De-ubiquitination, i.e. the removal of ubiquitin from proteins and peptides to which ubiquitin is attached, is catalyzed by processing proteases known as de-ubiquitinating enzymes. We are studying the ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204553

    authors: Soncini C,Berdo I,Draetta G

    更新日期:2001-06-28 00:00:00